Biomarker Rule-in or Rule-out in Patients With Acute Diseases for Validation of Acute Kidney Injury in the Emergency Department (BRAVA): A Multicenter Study Evaluating Urinary TIMP-2/IGFBP7

BACKGROUND: Urine tissue inhibitor of metalloproteinases-2/insulin-like growth factor-binding protein 7 (TIMP-2/IGFBP7) (NephroCheck, Ortho Clinical Diagnostics, Raritan, NJ, USA) is a US Food and Drug Administration-approved biomarker for risk assessment of acute kidney injury (AKI) in critically i...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Hyun Suk, Hur, Mina, Lee, Kyeong Ryong, Kim, Hanah, Kim, Hahn Young, Kim, Jong Won, Chua, Mui Teng, Kuan, Win Sen, Chua, Horng Ruey, Kitiyakara, Chagriya, Phattharapornjaroen, Phatthranit, Chittamma, Anchalee, Werayachankul, Thiyapha, Anandh, Urmila, Herath, Sanjeeva, Endre, Zoltan, Horvath, Andrea Rita, Antonini, Paola, Di Somma, Salvatore
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Society for Laboratory Medicine 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8548247/
https://www.ncbi.nlm.nih.gov/pubmed/34635611
http://dx.doi.org/10.3343/alm.2022.42.2.178

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8548247/
https://www.ncbi.nlm.nih.gov/pubmed/34635611
http://dx.doi.org/10.3343/alm.2022.42.2.178

Ejemplares similares